MUSTANG BIO, INC. (MBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD.

Revenue TTM

-60K -40K -20K 0 20K 40K 60K Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 50K Q2 '18: 50K Q3 '18: 50K Q4 '18: 0 Q1 '19: -50K Q2 '19: -50K Q3 '19: -50K Q4 '19: 0 Q2 '16 Q4 '16 Q2 '17 Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '16: -4.4M Q4 '16: -11.4M Q1 '17: -13.8M Q2 '17: -18.5M Q3 '17: -23.9M Q4 '17: -31.8M Q1 '18: -34.9M Q2 '18: -34.5M Q3 '18: -35.1M Q4 '18: -31.2M Q1 '19: -34.5M Q2 '19: -39.5M Q3 '19: -41.8M Q4 '19: -45.9M Q1 '20: -47.7M Q2 '20: -51.6M Q3 '20: -52M Q4 '20: -56.8M Q1 '21: -60.4M Q2 '21: -60.7M Q3 '21: -67.3M Q4 '21: -66.7M Q1 '22: -71.3M Q2 '22: -75.1M Q3 '22: -76.8M Q4 '22: -76.2M Q1 '23: -72.8M Q2 '23: -68.5M Q3 '23: -60M Q4 '23: -49.3M Q1 '24: -38.2M Q2 '24: -32.8M Q3 '24: -24M Q4 '24: -16.2M Q1 '25: -11.3M Q2 '25: -3.6M Q3 '25: -2.8M Q4 '25: -2.4M Q1 '26: -3.2M Q2 '26: -3.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '16: -4.8M Q4 '16: -12.7M Q1 '17: -15M Q2 '17: -19.4M Q3 '17: -24.4M Q4 '17: -31.3M Q1 '18: -34.4M Q2 '18: -33.9M Q3 '18: -34.5M Q4 '18: -30.7M Q1 '19: -34M Q2 '19: -39.3M Q3 '19: -42M Q4 '19: -46.4M Q1 '20: -48.6M Q2 '20: -52.8M Q3 '20: -55.6M Q4 '20: -60M Q1 '21: -63.1M Q2 '21: -62.9M Q3 '21: -66.9M Q4 '21: -66.4M Q1 '22: -71.2M Q2 '22: -75.9M Q3 '22: -77.9M Q4 '22: -77.5M Q1 '23: -74.4M Q2 '23: -71.6M Q3 '23: -62.6M Q4 '23: -51.6M Q1 '24: -40.1M Q2 '24: -32.1M Q3 '24: -23.4M Q4 '24: -15.8M Q1 '25: -10.7M Q2 '25: -3.3M Q3 '25: -2.3M Q4 '25: -1.9M Q1 '26: -2.7M Q2 '26: -3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '16: -2.4M Q4 '16: -4.1M Q1 '17: -5.6M Q2 '17: -5.8M Q3 '17: -10M Q4 '17: -12.9M Q1 '18: -16.5M Q2 '18: -18.9M Q3 '18: -17.9M Q4 '18: -19.2M Q1 '19: -20.2M Q2 '19: -25.6M Q3 '19: -30.6M Q4 '19: -33.6M Q1 '20: -37.2M Q2 '20: -36M Q3 '20: -37.3M Q4 '20: -37.3M Q1 '21: -42.7M Q2 '21: -47.3M Q3 '21: -48.4M Q4 '21: -53.7M Q1 '22: -54.4M Q2 '22: -59.9M Q3 '22: -64.5M Q4 '22: -65.1M Q1 '23: -66.6M Q2 '23: -61.4M Q3 '23: -57.5M Q4 '23: -49.5M Q1 '24: -37M Q2 '24: -26.9M Q3 '24: -16.7M Q4 '24: -11.4M Q1 '25: -7.5M Q2 '25: -6.5M Q3 '25: -5.5M Q4 '25: -5.3M Q1 '26: -4.9M Q2 '26: -4.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q2 '18: -24.7M Q3 '18: -24.9M Q4 '18: -26.1M Q1 '19: -26.7M Q2 '19: -28M Q3 '19: -32.4M Q4 '19: -35.9M Q1 '20: -39.8M Q2 '20: -38.5M Q3 '20: -39.5M Q4 '20: -39.2M Q1 '21: -44.6M Q2 '21: -50.3M Q3 '21: -51.7M Q4 '21: -57.7M Q1 '22: -59.2M Q2 '22: -63.3M Q3 '22: -68.5M Q4 '22: -67.8M Q1 '23: -68M Q2 '23: -62.5M Q3 '23: -57.6M Q4 '23: -49.5M Q3 '18 Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '21: 80.5M Q2 '21: 87.6M Q3 '21: 91.1M Q1 '22: 7.3M Q2 '22: 7.7M Q3 '22: 7.9M Q1 '23: 8.1M Q2 '23: 8.1M Q3 '23: 8.2M Q1 '24: 209.2K Q2 '24: 446.6K Q3 '24: 720.9K Q1 '25: 2.9M Q2 '25: 4M Q3 '25: 6.2M Q1 '26: 6.7M Q2 '26: 6.7M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-450.00 -300.00 -150.00 0.00 150.00 300.00 450.00 Q3 '16: -0.48 Q4 '16: -1.03 Q1 '17: -1.08 Q2 '17: -1.18 Q3 '17: -1.26 Q4 '17: -1.23 Q1 '18: -1.33 Q2 '18: -1.31 Q3 '18: -1.32 Q4 '18: -1.14 Q1 '19: -1.24 Q2 '19: -1.34 Q3 '19: -1.31 Q4 '19: -1.29 Q1 '20: -1.23 Q2 '20: -1.26 Q3 '20: -1.24 Q4 '20: -1.15 Q1 '21: -1.06 Q2 '21: -0.90 Q3 '21: -0.86 Q4 '21: -0.76 Q1 '22: -3.28 Q2 '22: -5.62 Q3 '22: -7.85 Q4 '22: -10.11 Q1 '23: -9.46 Q2 '23: -8.96 Q3 '23: -7.77 Q4 '23: -299.95 Q1 '24: -322.70 Q2 '24: -339.06 Q3 '24: -339.79 Q4 '24: -38.57 Q1 '25: -13.81 Q2 '25: 4.36 Q3 '25: 6.25 Q4 '25: -0.38 Q1 '26: -0.47 Q2 '26: -0.44 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.